Hong Shao

Hong Shao

Auto-generated profile, based on publicly available information

Hong Shao

Peking University School of Pharmaceutical Sciences, Beijing, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
MRMelody Ryan
Melody Ryan
HSHong Shao
Hong Shao
LYLi Yang
Li Yang
XNXiao-yan Nie
Xiao-yan Nie
SZSuo-Di Zhai
Suo-Di Zhai
WLWilliam C. Lubawy
William C. Lubawy
Pharmacy education in China focuses on pharmaceutical sciences, with the bachelor of science (BS) of pharmacy as the entry-level degree. Pharmacy practice curricula in these programs are centered on compounding, dispensing, pharmacy administration, and laboratory experiences, which are the traditional responsibilities for pharmacists. Additional graduate-level training is available at the master of science (MS) and the doctor of philosophy (PhD) levels, most of which concentrate on drug discovery and drug development research. Presently, the emphasis in practice is beginning to shift to clinical pharmacy. With this change, additional degree offerings are being developed to meet the growing demand for clinical pharmacists. There is also interest in developing more clinical skills in practicing pharmacists through additional non-degree training. The Ministry of Education is considering a proposal for an entry-level professional degree of master and/or doctor in clinical pharmacy similar to the doctor of pharmacy (PharmD) degree in the United States.

14 July 2008 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
YZYa‐Tong Zhang
Ya‐Tong Zhang
LYLi‐Ping Yang
Li‐Ping Yang
HSHong Shao
Hong Shao
KLKe‐Xin Li
Ke‐Xin Li
CSChun‐Hua Sun
Chun‐Hua Sun
LSLu‐Wen Shi
Lu‐Wen Shi
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Numerous studies have shown that MDR1 polymorphisms in the form of single nucleotide poymorphisms or haplptype affect ciclosporin pharmacokinetics or blood concentrations in organ transplantation patients, but some results conflict with others.WHAT THIS STUDY ADDS• We had thought that the diease condition might conceal the minor effect of MDR1 polymorphisms.• We chose myasthenia gravis patients as a population in which disease conditions were less severe.• We also used different pharmacokinetics indices, such as dose‐adjusted trough blood concentrations, dose‐adjusted peak blood concentrations and trough blood concentrations under the same ciclosporin regimen.AIMSCiclosporin (CsA), which is widely used in autoimmune disease and transplantation, has a narrow therapeutic index. It also shows considerable interindividual variability in its pharmacokinetics, which may be attributable to polymorphisms of the multidrug efflux pump P‐glycoprotein, encoded by MDR‐1. The aim was to determine the role of genetic polymorphisms in MDR‐1 with respect to interindividual variability of CsA blood concentrations in myasthenia gravis (MG) patients.METHODSMG patients (n = 129) receiving CsA were genotyped for MDR‐1 1236C→T (exon 12), 2677G→T (exon 21) and 3435C→T (exon 26). Trough blood and peak blood concentrations were determined to see if there was correlation with the corresponding genotype.RESULTSWe observed a trend for CsA blood concentrations, especially peak blood concentrations, to be higher with the wild‐type allele compared with minor alleles in genotype and haplotype. Furthermore, under the same CsA regimen, it was found that the trough concentrations of variant genotype (ABCB1 1236TT or ABCB1 2677TT) were significant greater than those of wild‐type (ABCB1 1236CC or ABCB1 2677GG, respectively) (P = 0.0222 and 0.0081). The trough concentrations of wild‐type haplotype pair group were significantly lower those that of the mutant type pair group (TT‐TT‐TT) (P = 0.007).CONCLUSIONSABCB1 polymorphisms in both genotype and haplotype may have a minor effect on the CsA blood concentrations.

15 March 2016 in Journal of Chinese Pharmaceutical Sciences
Verified
Journal Article
Open access
HSHong Shao
Hong Shao